Praxis precision medicines to provide corporate update and report third quarter 2021 financial results on wednesday, november 3, 2021

Boston, oct. 22, 2021 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal imbalance, today announced that it will provide a corporate update and report financial results for the third quarter 2021 on wednesday, november 3, 2021, before the u.s. financial markets open. management will discuss recent business and pipeline progress via a conference call and webcast at 8:30 a.m. et.
PRAX Ratings Summary
PRAX Quant Ranking